Intravenous Solutions Market by Manufacturers, Regions, Type and Application, Forecast to 2023

0
10

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Scope of the Report:
This report focuses on the Intravenous Solutions in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.

The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.

 

Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.

 

USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.

The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Intravenous Solutions is expected to grow at a CAGR of roughly 2.0% over the next five years, will reach 1930 million US$ in 2023, from 1710 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Crystalloids
Colloids
Others

Market Segment by Applications, can be divided into
Basic IV Solutions
Nutrient Infusion Solution
Others

There are 15 Chapters to deeply display the global Intravenous Solutions market.
Chapter 1, to describe Intravenous Solutions Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intravenous Solutions, with sales, revenue, and price of Intravenous Solutions, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Solutions, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intravenous Solutions market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intravenous Solutions sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here